Maternal sirolimus therapy and fetal growth restriction
Abstract
Keywords
Full Text:
PDFReferences
Malhotra A, Allison BJ, Castillo-Melendez M, Jenkin G, Polglase GR, Miller SL. Neonatal morbidities of fetal growth restriction: Pathophysiology and impact. Front Endocrinol (Lausanne) 2019; 10:1–18.
Gupta MB, Jansson T. Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth. Biol Reprod 2019; 100(4):872–884.
Roos S, Jansson N, Palmberg I, Säljö K, Powell TL, Jansson T. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol 2007; 582(1):449–459.
Dong J, Shin N, Chen S, Lei J, Burd I, Wang X. Is there a definite relationship between placental mTOR signaling and fetal growth? Biol Reprod 2020; 103(3):471–486.
Soblet J, Kangas J, Nätynki M, et al. Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations. J Invest Dermatol 2017; 137(1):207–216.
Terata M, Kikuchi A, Kanasugi T, Fukushima A, Sugiyama T. Association of blue rubber bleb nevus syndrome and placenta previa: Report of a case. J Clin Ultrasound 2013; 41(8):517–520.
Framarino-Dei-Malatesta M, Derme M, Napoli A, et al. Placental, lipid, and glucidic effects of mammalian target of rapamycin inhibitors: Impact on fetal growth and metabolic disorders during pregnancy after solid organ transplantation. Transplant Proc 2014; 46(7):2254–2258. http://dx.doi.org/10.1016/j.transproceed.2014.07.047.
Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006; 82(12):1698–1702.
Armenti VT, Radomski JS, Moritz MJ, et al. Report from the national transplantation pregnancy registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl 2001:97-105. PMID: 12211807.
Shen L, Xu W, Gao J, et al. Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM). Orphanet J Rare Dis 2021; 16(1):1–7. https://doi.org/10.1186/s13023-021-01776-7.
Pluym ID, Sklansky M, Wu JY, et al. Fetal cardiac rhabdomyomas treated with maternal sirolimus. Prenat Diagn 2020; 40(3):358–364.
Barnes BT, Procaccini D, Crino J, et al. Maternal sirolimus therapy for fetal cardiac rhabdomyomas. N Engl J Med 2018; 378(19):1844-1845. doi: 10.1056/NEJMc1800352. PMID: 29742370; PMCID: PMC6201692.
Park H, Chang CS, Choi SJ, Oh S young, Roh CR. Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis. Obstet Gynecol Sci 2019; 62(4):280–284.
Chu S, Liu K, Chiang Y, Wang H, Lai P. Sirolimus Used During Pregnancy in a Living Related Renal Transplant Recipient : A Case Report. 2008; 2448(5):2446–2448.
Framarino Dei Malatesta M, Corona LE, et al. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. Transplantation 2011; 91(9):69–71.
MacDonald AS, Scarola J, Burke JT, Zimmerman JJ. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 2000; 22 Suppl B:B101-121. doi: 10.1016/s0149-2918(00)89027-x.
Barlow AD, Nicholson ML, Herbert TP. Evidence for rapamycin toxicity in pancreatic β-Cells and a review of the underlying molecular mechanisms. Diabetes 2013; 62(8):2674–2682.
Laribee RN. Transcriptional and Epigenetic Regulation by the Mechanistic Target of Rapamycin Complex 1 Pathway. J Mol Biol 2018; 430(24):4874–4890.
Elghazi L, Blandino-Rosano M, Alejandro E, Cras-Méneur C, Bernal-Mizrachi E. Role of nutrients and mTOR signaling in the regulation of pancreatic progenitors development. Mol Metab 2017; 6(6):560–573.
Robinson JF, Hamilton EG, Lam J, Chen H, Woodruff TJ. Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues. Placenta 2020; 100(10):35–44.
Hakkola J, Raunio H, Purkunen R, et al. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate 2001; 80(3):193–201.
Dai C, Walker JT, Shostak A, et al. Tacrolimus- And sirolimus-induced human β cell dysfunction is reversible and preventable. JCI Insight 2020; 5(1):e130770. https://doi.org/10.1172/jci.insight.130770.
Hakkola J, Pelkonen O, Fasanen M, Raunio H. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto- placental unit: Role in intrauterine toxicity. Crit Rev Toxicol 1998; 28(1):35–72.
O’Callaghan JL, Clifton VL, Prentis P, Ewing A, Miller YD, Pelzer ES. Modulation of placental gene expression in small-for-gestational-age infants. Genes (Basel) 2020; 11(1):80. doi: 10.3390/genes11010080. PMID: 31936801; PMCID: PMC7017208.
Wang T, Tsui B, Kreisberg JF, et al. Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment. Genome Biol 2017; 1–11.
Lazo-De-La-Vega-Monroy ML, Mata-Tapia KA, Garcia-Santillan JA, et al. Association of placental nutrient sensing pathways with birth weight. Reproduction 2020; 160(3):455–468.
Figueras F, Caradeux J, Crispi F, Eixarch E, Peguero A, Gratacos E. Diagnosis and surveillance of late-onset fetal growth restriction. Am J Obstet Gynecol 2018; 218(2S):S790-S802.e1. doi: 10.1016/j.ajog.2017.12.003.
Goto E. Prediction of low birthweight and small for gestational age from symphysis-fundal height mainly in developing countries: A meta-analysis. J Epidemiol Community Health 2013; 67(12):999–1005.
Chauhan SP, Beydoun H, Chang E, et al. Prenatal detection of fetal growth restriction in newborns classified as small for gestational age: correlates and risk of neonatal morbidity. Am J Perinatol 2014; 31(3):187–194.
DOI: http://dx.doi.org/10.22551/2021.31.0802.10180
Copyright (c) 2021 Sangay Tshering, Namkha Dorji, Sonam Youden, Dorji Wangchuk
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975